Standard Medicare Part B Management Aucatzyl
Customize your policy alerts
Sign up for clover_health Policy 6731-A alerts
Get alerted when Policy 6731-A changes without checking for updates manually.
Monitor payer policy activity
This policy governs Medicare Part B coverage and prior authorization for Aucatzyl in adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia or lymphoblastic lymphoma, subject to disease, treatment-history, CD19-expression, functional-status, and safety criteria.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.